| RS2505880000 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2505887113 |
CACNA1C
|
Health Risk |
Likely pathogenic |
CACNA1C-related disorder, CACNA1C-related disorder |
| RS2505888715 |
CEP152
|
Health Risk |
Pathogenic |
Microcephaly 9, primary |
| RS2505891787 |
NIN
|
Health Risk |
Likely pathogenic |
Seckel syndrome 7, Seckel syndrome 7 |
| RS2505904065 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2505905528 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brugada syndrome |
| RS2505905536 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505906188 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2505907513 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2505910497 |
TELO2
|
Health Risk |
Pathogenic |
— |
| RS2505910980 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505910996 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2505911590 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505911861 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505926819 |
TELO2
|
Health Risk |
Likely pathogenic |
— |
| RS2505926865 |
ANK2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505931024 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS2505931124 |
ANK2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2505931126 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS2505931142 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS2505933210 |
ANK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2505933639 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS2505936870 |
PIGQ
|
Health Risk |
Pathogenic |
PIGQ-related disorder, Epilepsy |
| RS2505951722 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505951838 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505951948 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505959955 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2505965079 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2505966575 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2505968287 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2505968683 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2505968895 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2505969779 |
IGF1R
|
Health Risk |
Pathogenic |
— |
| RS2505969978 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505970054 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505970769 |
CIB1
|
Health Risk |
Pathogenic |
— |
| RS2505980836 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2505980883 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2505981458 |
IGF1R
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2505983529 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2505983816 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2505983851 |
ABCD4
|
Health Risk |
Pathogenic |
Methylmalonic acidemia with homocystinuria, type cblJ |
| RS2505984516 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group I |
| RS2505984539 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2505987224 |
TELO2
|
Health Risk |
Pathogenic |
— |
| RS2505994536 |
ANK2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2506014488 |
IGF1R
|
Health Risk |
Pathogenic |
— |
| RS2506023488 |
IGF1R
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2506034722 |
IGF1R
|
Health Risk |
Pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS2506039306 |
GRIN2A
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS2506039338 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506058863 |
IGF1R
|
Health Risk |
Pathogenic/Likely pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS2506059210 |
IGF1R
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2506064268 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2506064389 |
OCA2
|
Health Risk |
Likely pathogenic |
— |
| RS2506064523 |
CDAN1
|
Health Risk |
Likely pathogenic |
— |
| RS2506064927 |
OCA2
|
Health Risk |
Likely pathogenic |
OCA2-related disorder, OCA2-related disorder |
| RS2506065436 |
OCA2
|
Health Risk |
Pathogenic |
OCA2-related disorder, OCA2-related disorder |
| RS2506065459 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2506065990 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2506067560 |
CDAN1
|
Health Risk |
Likely pathogenic |
Anemia, congenital dyserythropoietic |
| RS2506069523 |
IGF1R
|
Health Risk |
Likely pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS2506072003 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2506072089 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2506077768 |
CDAN1
|
Health Risk |
Pathogenic |
— |
| RS2506082363 |
CDAN1
|
Health Risk |
Pathogenic |
— |
| RS2506085601 |
CDAN1
|
Health Risk |
Pathogenic |
— |
| RS2506088522 |
CDAN1
|
Health Risk |
Pathogenic |
— |
| RS2506091121 |
IGF1R
|
Health Risk |
Likely pathogenic |
— |
| RS2506092231 |
CDAN1
|
Health Risk |
Likely pathogenic |
Anemia, congenital dyserythropoietic |
| RS2506094292 |
MYH11
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS2506094595 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506094829 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506094896 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506095528 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS2506101144 |
CDAN1
|
Health Risk |
Pathogenic |
Anemia, congenital dyserythropoietic |
| RS2506102659 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2506103002 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2506103419 |
MYH11
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS2506104244 |
MYH11
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS2506104379 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506104570 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506104627 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506104683 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506107051 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506107075 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506107168 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506107182 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506107250 |
NPC2
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C2 |
| RS2506107289 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506107370 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2506111320 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506111442 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506111451 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS2506111725 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506111827 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506111835 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2506112058 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2506113141 |
SPG21
|
Health Risk |
Conflicting classifications of pathogenicity |
Mast syndrome, Mast syndrome |
| RS2506113603 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |